Novozymes Total Liabilities and Share Holders Equity 2011-2024 | NVZMY
Novozymes total liabilities and share holders equity from 2011 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Novozymes total liabilities and share holders equity for the quarter ending June 30, 2024 was $4.122B, a 4.04% increase year-over-year.
- Novozymes total liabilities and share holders equity for 2024 was $16.443B, a 298.88% increase from 2023.
- Novozymes total liabilities and share holders equity for 2023 was $4.122B, a 4.04% increase from 2022.
- Novozymes total liabilities and share holders equity for 2022 was $3.962B, a 0.56% increase from 2021.
Novozymes Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024 |
$16,443 |
| 2023 |
$4,122 |
| 2022 |
$3,962 |
| 2021 |
$3,940 |
| 2020 |
$3,142 |
| 2019 |
$3,064 |
| 2018 |
$3,120 |
| 2017 |
$2,791 |
| 2016 |
$2,773 |
| 2015 |
$2,647 |
| 2014 |
$3,285 |
| 2013 |
$2,889 |
| 2012 |
$2,612 |
| 2011 |
$2,588 |
| 2010 |
$2,242 |
Novozymes Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023-12-31 |
$4,122 |
| 2023-09-30 |
$4,167 |
| 2023-06-30 |
$4,124 |
| 2023-03-31 |
$4,076 |
| 2022-12-31 |
$3,962 |
| 2022-09-30 |
$3,785 |
| 2022-06-30 |
$3,789 |
| 2022-03-31 |
$3,812 |
| 2021-12-31 |
$3,940 |
| 2021-09-30 |
$3,462 |
| 2021-06-30 |
$3,504 |
| 2021-03-31 |
$3,515 |
| 2020-12-31 |
$3,142 |
| 2020-09-30 |
$3,160 |
| 2020-06-30 |
$3,059 |
| 2020-03-31 |
$3,016 |
| 2019-12-31 |
$3,064 |
| 2019-09-30 |
$3,003 |
| 2019-06-30 |
$3,021 |
| 2019-03-31 |
$3,104 |
| 2018-12-31 |
$3,120 |
| 2018-09-30 |
$2,964 |
| 2018-06-30 |
$3,019 |
| 2018-03-31 |
$3,060 |
| 2017-12-31 |
$2,791 |
| 2017-09-30 |
$2,853 |
| 2017-06-30 |
$2,671 |
| 2017-03-31 |
$2,705 |
| 2016-12-31 |
$2,773 |
| 2016-09-30 |
$2,672 |
| 2016-06-30 |
$2,697 |
| 2016-03-31 |
$2,589 |
| 2015-12-31 |
$2,647 |
| 2015-09-30 |
$2,671 |
| 2015-06-30 |
$2,716 |
| 2015-03-31 |
$2,800 |
| 2014-12-31 |
$3,285 |
| 2014-09-30 |
$3,359 |
| 2014-06-30 |
$3,348 |
| 2014-03-31 |
$3,248 |
| 2013-12-31 |
$2,889 |
| 2013-09-30 |
$2,828 |
| 2013-06-30 |
$2,821 |
| 2013-03-31 |
$2,863 |
| 2012-12-31 |
$2,612 |
| 2012-09-30 |
$2,443 |
| 2012-06-30 |
$2,450 |
| 2012-03-31 |
$2,406 |
| 2011-12-31 |
$2,588 |
| 2011-09-30 |
$2,593 |
| 2011-06-30 |
$2,543 |
| 2011-03-31 |
$2,400 |
| 2010-12-31 |
$2,242 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$29.315B |
$4.149B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
